| Date Filed | Type | Description |
| 06/16/2023 |
4
| Diamandis Peter (Director) has filed a Form 4 on Celularity Inc|
Txns:
| Granted 199,921 shares
@ $0
Granted 277,778 options to buy
@ $0.7503, valued at
$208.4k
|
|
| 05/02/2023 |
4
| Diamandis Peter (Director) has filed a Form 4 on Vaxxinity, Inc.|
Txns:
| Exercised 429,037 options to buy
@ $0.57, valued at
$244.6k
Exercised 46,500 options to buy
@ $1.21, valued at
$56.3k
|
|
| 02/14/2023 |
4
| Diamandis Peter (Director) has filed a Form 4 on Celularity Inc|
Txns:
| Exercised 1,071,000 options to buy
@ $0.28, valued at
$299.9k
|
|
| 08/09/2022 |
4
| Diamandis Peter (Director) has filed a Form 4 on DPCM Capital, Inc.|
Txns:
| Converted 45,000 shares
@ $0
Disposed of 45,000 shares
@ $0
Converted 45,000 options to buy
@ $0 |
|
| 07/15/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/23/2022 |
4
| Diamandis Peter (Director) has filed a Form 4 on Vaxxinity, Inc.|
Txns:
| Granted 129,187 options to buy
@ $2.09, valued at
$270k
|
|
| 06/23/2022 |
4/A
| Diamandis Peter (Director) has filed a Form 4 on Vaxxinity, Inc.|
Txns:
| Paid exercise price by delivering 312,659 shares
@ $8.6, valued at
$2.7M
|
|
| 06/23/2022 |
4/A
| Diamandis Peter (Director) has filed a Form 4 on Vaxxinity, Inc.|
Txns:
| Sold 248 shares
@ $13, valued at
$3.2k
|
|
| 06/23/2022 |
4/A
| Diamandis Peter (Director) has filed a Form 4 on Vaxxinity, Inc.|
Txns:
| Converted 13,824 shares
@ $0
Converted 13,824 shares
@ $0
Converted 21,511 preferred shares
@ $0 |
|
| 06/23/2022 |
3/A
| Diamandis Peter (Director) has filed a Form 3/A on Vaxxinity, Inc. |
| 01/26/2022 |
4
| Diamandis Peter (Director) has filed a Form 4 on Vaxxinity, Inc.|
Txns:
| Exercised 652,764 options to buy
@ $4.1192, valued at
$2.7M
|
|
| 11/18/2021 |
4
| Diamandis Peter (Director) has filed a Form 4 on Vaxxinity, Inc.|
Txns:
| Disposed of 76,923 shares
@ $0
Acquired 76,923 shares
@ $0 |
|
| 11/15/2021 |
4
| Diamandis Peter (Director) has filed a Form 4 on Vaxxinity, Inc.|
Txns:
| Converted 271,655 shares
@ $0
Bought 76,923 shares
@ $0
Converted 21,511 preferred shares
@ $0 |
|
| 11/10/2021 |
3
| Diamandis Peter (Director) has filed a Form 3 on Vaxxinity, Inc. |
| 09/13/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/28/2021 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 07/20/2021 |
4
| Diamandis Peter (Director) has filed a Form 4 on Celularity Inc|
Txns:
| Granted 3,731,136 options to buy
@ $0.28, valued at
$1M
Granted 269,007 options to buy
@ $3.83, valued at
$1M
|
|
| 07/16/2021 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 11/20/2020 |
4
| Diamandis Peter (Former Director) has filed a Form 4 on CuriosityStream Inc.|
Txns:
| Disposed of 3,737,500 shares
@ $0
Acquired 20,000 shares
@ $0 |
|
| 10/20/2020 |
3
| Diamandis Peter (Director) has filed a Form 3 on DPCM Capital, Inc. |
| 09/14/2020 |
3
| Diamandis Peter (Director) has filed a Form 3 on Software Acquisition Group Inc. II |
| 11/19/2019 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 05/21/2015 |
4
| Diamandis Peter (Director) has filed a Form 4 on 3D SYSTEMS CORP|
Txns:
| Granted 3,000 shares
@ $0 |
|
| 01/12/2015 |
4
| Diamandis Peter (Director) has filed a Form 4 on MYOS Corp|
Txns:
| Granted 4,000 options
@ $12.5, valued at
$50k
|
|
| 08/18/2014 |
4
| Diamandis Peter (Director) has filed a Form 4 on MYOS Corp|
Txns:
| Bought 3,444 shares
@ $14.51, valued at
$50k
|
|
| 05/20/2014 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 03/12/2014 |
4
| Diamandis Peter (Director) has filed a Form 4 on MYOS Corp|
Txns:
| Granted 2,500 options
@ $8.6, valued at
$21.5k
|
|
| 07/29/2013 |
3
| Diamandis Peter (Director) has filed a Form 3 on 3D SYSTEMS CORP |
| 01/09/2013 |
4
| Diamandis Peter (Director) has filed a Form 4 on MYOS Corp|
Txns:
| Granted 250,000 options
@ $0.25, valued at
$62.5k
|
|
| 08/19/2011 |
3
| Diamandis Peter (Director) has filed a Form 3 on Atlas Therapeutics Corp |
| 08/19/2011 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |